Skip to main content
Walvax Biotechnology Co.,Ltd. logo

Walvax Biotechnology Co.,Ltd. — Investor Relations & Filings

Ticker · 300142 ISIN · CNE100000WN2 LEI · 300300H82R2DIQXA8N24 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,790 across all filing types
Latest filing 2021-04-16 Declaration of Voting R…
Country CN China
Listing Shenzhen Stock Exchange 300142

About Walvax Biotechnology Co.,Ltd.

https://www.walvax.com

Walvax Biotechnology Co.,Ltd. is a biopharmaceutical enterprise specializing in the research, development, production, and distribution of vaccines and other biological products. The company focuses on modern biotechnology to address public health challenges through a diverse portfolio of preventive vaccines. Key products include the 13-valent pneumococcal polysaccharide conjugate vaccine (PCV13), the bivalent human papillomavirus (HPV) vaccine, and various combination vaccines for meningitis and Haemophilus influenzae type b (Hib). Walvax operates advanced R&D platforms and manufacturing facilities that comply with international quality standards. The company is actively involved in the development of next-generation vaccine technologies, including mRNA and recombinant protein platforms, aiming to provide affordable and high-quality immunization solutions for global markets.

Recent filings

Filing Released Lang Actions
2020年年度股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the 2020 Annual General Meeting (AGM) of Yunnan Watson Biotechnology Co., Ltd. It includes voting results on various agenda items such as the 2020 board work report, supervisory board report, audited financial report, annual report, profit distribution plan, and project adjustments. The document also confirms the legality and validity of the meeting and voting procedures, with legal opinions attached. The content focuses on the official results of shareholder votes at the AGM, which matches the definition of 'Declaration of Voting Results & Voting Rights Announcements (DVA)'. The document length is 4144 characters, which is relatively short but contains detailed voting results rather than just an announcement of a report publication. Therefore, it is not a Report Publication Announcement (RPA). It is not a full Annual Report (10-K) or other report type, but specifically the voting results announcement from the AGM.
2021-04-16 Chinese
北京国枫（深圳）律师事务所关于公司2020年年度股东大会的法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter from a law firm regarding the 2020 Annual General Meeting (AGM) of Yunnan Watson Biotechnology Co., Ltd. It details the convening, attendance, voting procedures, and results of the 2020 AGM. The document includes specific voting results on various proposals including the 2020 annual report and profit distribution plan. The content focuses on the legal compliance and validity of the AGM process and voting outcomes, which aligns with the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document is not the annual report itself, nor is it a simple announcement of a report publication. It is a detailed legal opinion on the AGM and the voting results, fitting the DVA category.
2021-04-16 Chinese
关于子公司收到境外发明专利证书的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement from a company about its subsidiary receiving a foreign invention patent certificate. It contains no financial data, no discussion of financial results, no regulatory certifications, or meeting materials. It is not a report or a filing related to financial performance or governance changes. It is a regulatory announcement about intellectual property rights. Given the content and length (690 characters), it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous announcements that do not fit other specific categories.
2021-04-12 Chinese
关于召开2020年年度股东大会的提示性公告
AGM Information Classification · 100% confidence The document is a detailed announcement about the convening of the 2020 Annual General Meeting (AGM) of Yunnan Watson Biotechnology Co., Ltd. It includes information about the meeting date, voting procedures, proposals to be discussed, registration details, and attachments such as proxy forms and voting instructions. It does not contain the actual annual report or financial statements but rather serves as a notice and guide for shareholders to participate in the AGM. The document length is 4746 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document fits the category of AGM Information (AGM-R).
2021-04-09 Chinese
2021年第一季度业绩预告
Earnings Release Classification · 95% confidence The document is a quarterly earnings forecast for the first quarter of 2021 by Yunnan Watson Biotechnology Co., Ltd. It includes estimated net profit figures, comparison with the previous year, and explanations for performance changes. The document explicitly states that the data is preliminary and unaudited, and that detailed financial data will be disclosed in the first quarter report. This type of document is an Earnings Release (ER) as it provides initial announcement of quarterly financial results with key highlights only, not the full interim report. The document length is short (929 characters), but it contains substantive financial estimates and explanations, fitting the ER category rather than a report publication announcement or regulatory filing. Q1 2021
2021-04-08 Chinese
关于子公司完成工商变更登记的公告
Share Issue/Capital Change Classification · 95% confidence The document is a company announcement regarding the completion of a business registration change for a subsidiary, specifically about an increase in capital and the registration of that change with the relevant authorities. It includes details about the subsidiary's business license and registration information. The document is short (782 characters) and does not contain financial statements or detailed financial data. It is an announcement of a capital change related to a subsidiary, not a full financial report or audit. Therefore, it fits best under the category of Share Issue/Capital Change (SHA), which covers announcements regarding new share issues or capital changes.
2021-04-01 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.